US officials hopeful as advisers meet again on J&J Covid-19 vaccine
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
US officials hopeful as advisers meet again on J&J Covid-19 vaccine

Coronavirus chronicle

Reuters
23 April, 2021, 09:10 pm
Last modified: 23 April, 2021, 09:24 pm

Related News

  • China relaxes some Covid test rules for US, other travellers
  • US reopens embassy in Kyiv after closure forced by war
  • Monkeypox cases are on rise in Europe and US, here is why
  • US to suggest tariffs on Russian oil as alternative to embargoes
  • US Air Force says it conducted successful hypersonic weapon test

US officials hopeful as advisers meet again on J&J Covid-19 vaccine

Some panel members argued an extension of the pause could signal to the world that the vaccine had major safety issues

Reuters
23 April, 2021, 09:10 pm
Last modified: 23 April, 2021, 09:24 pm
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

Advisers to the US Centers for Disease Control and Prevention will meet again on Friday to consider whether it is safe to resume injections of Johnson & Johnson's Covid-19 vaccine, as senior US health officials prepare for a green light.

The panel last week called for more data about a possible link to rare blood clots in the brain before deciding how and whether to end a "pause" in administration of J&J vaccines called for by the CDC and the Food and Drug Administration.

The decision by CDC's advisory panel has global implications since J&J's immunization is seen as an important tool for poorer countries and less accessible populations, given that it only requires one dose and can be stored at normal refrigerator temperatures, making it relatively easy to transport.

Some panel members argued an extension of the pause could signal to the world that the vaccine had major safety issues. There have been six reported cases of rare brain blood clots accompanied by low platelets in the blood out of nearly 8 million doses administered in the United States. US officials last week said a handful more possible cases were under review.

State health officials on Thursday said the CDC was investigating two more possible cases, probing the death of an Oregon woman in her 50s and the hospitalization a Texas woman with symptoms similar to those found in the clot cases - both of whom had received J&J's shot. Officials have not linked the cases to the vaccine.

The United States has ordered enough doses of vaccines from Pfizer Inc/BioNTech and Moderna Inc to cover all US adults, but many senior regulators, including US infectious disease chief Anthony Fauci, have signaled they hope to resume use of the J&J vaccine.

CDC Director Dr. Rochelle Walensky said she was hopeful for a quick decision on J&J's vaccine, especially as EU regulators backed the shot this week, and added US advisers on Friday would review data as well as the agency's risk/benefit analysis.

"I will look toward their guidance. I believe its really important to make a swift decision," she told NBC News' "Today" program on Thursday, adding that she expected US guidance to be issued soon after Friday's meeting.

The European Medicines Agency on Tuesday recommended adding a warning about unusual blood clots with low blood platelet counts to the vaccine's product label, saying that benefits of the shot outweighed the risks. The drugmaker has said it would resume rolling in the region.

US National Institutes of Health Director Dr. Francis Collins told ABC News' "Good Morning America" program on Friday the Europeans' decision to move ahead while adding a warning was "encouraging."

He added possible clots are "one in a million kind of risk" while "this vaccine can save lives" in the fight against a pandemic, which has already claimed more than 3.2 million lives globally, including at least 570,674 in the United States.

J&J has faced several setbacks since its shot gained US emergency authorization in February, first drawing scrutiny over its halting process to scale up production of the vaccine, and then over rare cases of clots in a handful of vaccine recipients. FDA inspectors this week cited serious cleanliness and medical safety issues at an Emergent BioSolutions  plant making the J&J vaccine. 

The company's shares were near flat in early morning pre-trade on Friday ahead of the meeting.

European regulators said the blood clots in patients who received the J&J vaccine bear close resemblance to 169 cases in Europe reported with the AstraZeneca Plc vaccine.

US officials said a key reason for their pause was to communicate the risk to doctors on how to recognize the side effects and treat them, saying patients with clot-related symptoms following the J&J vaccine should not be given heparin, a blood thinner widely used to treat clotting disorders.

"This is a treatable condition if you recognize it right away," Collins told ABC.

World+Biz

US / official / hopeful / advisers / J&J Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Students suffer over costlier food at public university canteens
    Students suffer over costlier food at public university canteens
  • A worker displays grains of wheat at a mill in Beirut, Lebanon, March 1, 2022. REUTERS/Mohamed Azakir/File Photo
    Russia can offer 25 mln tonnes of grain for export starting on 1 Aug: UN envoy
  • A model of the natural gas pipeline is seen in front of displayed Finnish and Russian flag colours in this illustration taken April 26, 2022. REUTERS/Dado Ruvic/Illustration
    Russian gas flows to Finland to stop on Saturday, says Gasum

MOST VIEWED

  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'
  • Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea's Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo
    North Korea hails 'good results' on Covid as fever cases pass 2 million
  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial
  • A woman wearing protective mask walks at a sidewalk near business district in Jakarta, Indonesia March 2, 2020. REUTERS/Willy Kurniawan/Files
    Indonesia to drop outdoor mask mandate as Covid-19 infections drop

Related News

  • China relaxes some Covid test rules for US, other travellers
  • US reopens embassy in Kyiv after closure forced by war
  • Monkeypox cases are on rise in Europe and US, here is why
  • US to suggest tariffs on Russian oil as alternative to embargoes
  • US Air Force says it conducted successful hypersonic weapon test

Features

Mohammad (Mejbah) Mejbahuddin, Former Senior Secretary, Economic Relations Division (ERD), Ministry of Finance, Government of Bangladesh. TBS Sketch

‘No project is being delayed too long at the moment’

1h | Panorama
Dr Shamsul Hoque, Professor, Civil Engineering, BUET. TBS Sketch

‘Planning commission only in the name, there are no planners’ 

1h | Panorama
Masrur Reaz. TBS Sketch

‘To ensure accountability, contract financing should be based on ‘performance based payments’

1h | Panorama
Professor Mustafizur Rahman. Illustration: TBS

Project delays and escalating costs are driven by frequent revisions and lack of good governance

4h | Panorama

More Videos from TBS

Ways to retain body fragrance

Ways to retain body fragrance

2h | Videos
Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

6h | Videos
How to prepare for a job

How to prepare for a job

7h | Videos
Putin's strategies to face Nato

Putin's strategies to face Nato

19h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

5
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab